Related Experiment Video
Updated: Apr 21, 2026

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
VEGF-mediated suppression of cell proliferation and invasion by miR-410 in osteosarcoma
Dong Zhao1, Peng Jia, Wenliang Wang
1Department of Orthopedics, Affiliated Hospital, Logistics University of Chinese People's Armed Police Forces, No. 220 Chenglin Road, Hedong district, Tianjin, 300162, China, zhaodongtj@163.com.
Abstract:
MicroRNAs (miRNAs) are small non-coding RNAs that post-transcriptionally regulate gene expression. The aberrant expression of miRNA has become a major focus in cancer research. This study aimed to investigate the importance of miR-410 in the diagnosis and therapy of osteosarcoma (OS). Western blot analysis showed that the expression of VEGF was higher in Saos-2 and MG-63 cells than that in three other OS cell lines. We also found that miR-410 was lowly expressed and inversely correlated with VEGF expression in OS specimens. Over-expression of miR-410 had a greater repression on VEGF expression than other candidate VEGF-targeting miRNAs. Luciferase reporter assay demonstrated that miR-410 directly decreased VEGF expression by targeting its 3'-untranslated region. Further investigation demonstrated the regulation of miR-410 in OS cells via VEGF. In vitro MTT assay, Transwell, and flow cytometry showed that transfection of the miR-410 expression plasmid inhibited cell proliferation and contributed to apoptosis in OS cells. Moreover, restoration of VEGF reversed the effect of miR-410 on OS cells, and upregulated the expression of phosphorylated AKT. Finally, overexpression of miR-410 also showed a negative effect on tumor growth in vivo. Our findings suggest a cooperative relationship between miR-410 and VEGF in OS cell regulation. This information may help researchers to better understand miRNA regulation in cancer and provide a rationale for developing miRNA-based strategies for OS treatment.
Insights
MicroRNA-410 (miR-410) is downregulated in osteosarcoma (OS) and inhibits tumor growth by targeting VEGF. Restoring miR-410 shows therapeutic potential for OS treatment.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- MicroRNAs (miRNAs) are key regulators of gene expression implicated in cancer.
- Aberrant miRNA expression is a hallmark of various cancers, including osteosarcoma (OS).
- Understanding specific miRNA roles in OS is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the role of miR-410 in osteosarcoma (OS) diagnosis and therapy.
- To determine the relationship between miR-410 and Vascular Endothelial Growth Factor (VEGF) in OS.
- To evaluate the therapeutic potential of miR-410 in OS.
Main Methods:
- Western blot analysis to assess protein expression (VEGF).
- Luciferase reporter assay to confirm direct targeting of VEGF by miR-410.
- In vitro assays (MTT, Transwell, flow cytometry) to evaluate effects on OS cells.
- In vivo studies to assess tumor growth inhibition.
Main Results:
- miR-410 was lowly expressed and inversely correlated with VEGF in OS specimens.
- miR-410 directly targeted and repressed VEGF expression.
- Overexpression of miR-410 inhibited OS cell proliferation, induced apoptosis, and suppressed tumor growth in vivo.
- Restoration of VEGF reversed the anti-tumor effects of miR-410.
Conclusions:
- miR-410 acts as a tumor suppressor in osteosarcoma by targeting VEGF.
- The miR-410/VEGF axis plays a significant role in OS cell regulation.
- miR-410 holds promise as a diagnostic marker and therapeutic target for osteosarcoma.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Regulation of Angiogenesis and Blood Supply
TGF - β Signaling Pathway
Mitogens and the Cell Cycle
MicroRNAs

